Calyxra Kit
NDC Package 84460-803-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Calyxra (calcipotriene cream, 0.005%) kits is do not use if known hypersensitivity to any of the listed ingredients of any of the components included on the kit. This formulation utilizes a kit delivery system. Marketed by Florrax Pharmaceutical, this product is identified by NDC 84460-803.

Identification & Billing

NDC Package Code
84460-803-01
Package Description
1 KIT in 1 KIT * 1 TUBE in 1 CARTON (68462-501-65) / 60 g in 1 TUBE * 10 in 1 BOX
Product Code
84460-803
11-Digit Billing Format
84460080301
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Calyxra
Non-Proprietary Name
Calcipotriene Cream, 0.005%
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Do not use if known hypersensitivity to any of the listed ingredients of any of the components included on the kit. Calcipotriene cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. It should not be used by patients with demonstrated hypercalcemia or evidence of vitamin D toxicity. Calcipotriene cream should not be used on the face.

Regulatory & Marketing

Labeler Name
Florrax Pharmaceutical
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-13-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84460-803-01 identifies a specific commercial package of 1 kit in 1 kit * 1 tube in 1 carton (68462-501-65) / 60 g in 1 tube * 10 in 1 box of Calyxra, a human prescription drug labeled by Florrax Pharmaceutical. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Florrax Pharmaceutical on January 13, 2023. The current certification is valid through December 31, 2027.

How is this Florrax Pharmaceutical product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84460080301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84460-803-01
11-Digit CMS (5-4-2)
84460-0803-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.